Neurocrine Biosciences (NBIX)
48.83
-0.17 -0.35%
NASDAQ
Jul 27, 20:00
Delayed 2m
USD
View All Key Stats
NBIX Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.31 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -200.15M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 4.301B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 17.40 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -78.72M |
| Return on Equity (TTM) | -- |
View All NBIX News
NBIX News
-
WireHeadlineTime (ET)
-
Yahoo07/28 03:56
-
Yahoo07/27 14:46
-
Yahoo07/25 08:00
-
PR Newswire07/21 09:28
-
PR Newswire07/10 11:10
-
Yahoo07/06 09:28
-
Yahoo07/05 08:26
-
Yahoo07/04 08:25
-
Yahoo07/03 09:01
-
Yahoo06/20 14:39
View All Events
NBIX Events
| Date | Type | Description |
|---|---|---|
| 05/22/2017 | Misc | Neurocrine Biosciences Inc Annual General Meeting in 2016 |
| 05/09/2017 17:00 EDT | Misc | Neurocrine Biosciences Inc First Quarter Earnings Conference Call in 2017 |
| 05/09/2017 | Earnings | Neurocrine Biosciences Inc First Quarter Earnings in 2017 Release |
| 02/14/2017 17:00 EST | Misc | Neurocrine Biosciences Inc Fourth Quarter Earnings Conference Call in 2016 |
| 02/14/2017 | Earnings | Neurocrine Biosciences Inc Fourth Quarter Earnings in 2016 Release |
| 11/02/2016 17:00 EDT | Misc | Neurocrine Biosciences Inc Third Quarter Earnings Conference Call in 2016 |
| 11/02/2016 | Earnings | Neurocrine Biosciences Inc Third Quarter Earnings in 2016 Release |
| 08/03/2016 17:00 EDT | Misc | Neurocrine Biosciences Inc Second Quarter Earnings Conference Call in 2016 |
| 08/03/2016 | Earnings | Neurocrine Biosciences Inc Second Quarter Earnings in 2016 Release |
NBIX Fundamentals
Income Statement View Statement
NBIX Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
NBIX One Page Reports
- One Page Report Download
NBIX Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 48.83 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.neurocrine.com
- Investor Relations URL: http://phoenix.corporate-ir.net/phoenix.zhtml?c=68817&p=irol-news&nyo=0
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: May. 09, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Dec. 29, 1995
- Description: Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.
NBIX Comparables
EditNBIX Excel Add-In Codes
- Name: =YCI("NBIX","name")
- Description: =YCI("NBIX","description")
- Sector: =YCI("NBIX","sector")
- Industry: =YCI("NBIX","industry")
- Est. Current Fiscal Year End: =YCI("NBIX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other NBIX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NBIX Tweets Stocktwits
Advertisement
